Steve Okada

Shunichiro Okada, also known as Steve, is a highly experienced individual currently serving as the Chief Medical Officer at Invea Therapeutics. Shunichiro (Steve) has a strong background in medical and pharmaceutical research, with previous roles at Takeda Pharmaceuticals, Novartis, GSK, and various academic institutions. Okada has extensive experience in cardiovascular and metabolic medicine, as well as stem cell therapies and drug development. Shunichiro (Steve) has a wide range of expertise in translational medicine, clinical strategy, and therapeutic development.